Latest news
Oral VH-499 monotherapy reduced HIV-1 viral load in a phase 2a trial - Vera HealthVera Health · Thu, 06 Aug 2026 02:23:16 GMTHIV-1 latency: CD8+ T cells may be an overlooked reservoir - Vera HealthVera Health · Sun, 02 Aug 2026 01:15:16 GMTHIV-1: Once-weekly oral islatravir–lenacapavir maintains virologic suppression after switch - Vera HealthVera Health · Wed, 29 Jul 2026 14:10:50 GMT